FDA Unveils Blueprint For Custom Gene-Editing Treatments

https://kffhealthnews.org/morning-breakout/fda-unveils-blueprint-for-custom-gene-editing-treatments/ The plan allows a company or academic group to craft custom treatments for “several” patients and then apply for approval. Rather than the FDA approving an individual, unchangeable drug, it would allow those creators to keep crafting bespoke editors for new individuals with new mutations, Stat explains.